Cargando…

Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK

BACKGROUND: Chemoresistance is a significant clinical problem in pancreatic cancer (PC) and underlying molecular mechanisms still remain to be completely understood. Here we report a novel exosome-mediated mechanism of drug-induced acquired chemoresistance in PC cells. METHODS: Differential ultracen...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Girijesh Kumar, Khan, Mohammad Aslam, Bhardwaj, Arun, Srivastava, Sanjeev K, Zubair, Haseeb, Patton, Mary C, Singh, Seema, Khushman, Moh'd, Singh, Ajay P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344296/
https://www.ncbi.nlm.nih.gov/pubmed/28152544
http://dx.doi.org/10.1038/bjc.2017.18
_version_ 1782513510553485312
author Patel, Girijesh Kumar
Khan, Mohammad Aslam
Bhardwaj, Arun
Srivastava, Sanjeev K
Zubair, Haseeb
Patton, Mary C
Singh, Seema
Khushman, Moh'd
Singh, Ajay P
author_facet Patel, Girijesh Kumar
Khan, Mohammad Aslam
Bhardwaj, Arun
Srivastava, Sanjeev K
Zubair, Haseeb
Patton, Mary C
Singh, Seema
Khushman, Moh'd
Singh, Ajay P
author_sort Patel, Girijesh Kumar
collection PubMed
description BACKGROUND: Chemoresistance is a significant clinical problem in pancreatic cancer (PC) and underlying molecular mechanisms still remain to be completely understood. Here we report a novel exosome-mediated mechanism of drug-induced acquired chemoresistance in PC cells. METHODS: Differential ultracentrifugation was performed to isolate extracellular vesicles (EVs) based on their size from vehicle- or gemcitabine-treated PC cells. Extracellular vesicles size and subtypes were determined by dynamic light scattering and marker profiling, respectively. Gene expression was examined by qRT-PCR and/or immunoblot analyses, and direct targeting of DCK by miR-155 was confirmed by dual-luciferase 3′-UTR reporter assay. Flow cytometry was performed to examine the apoptosis indices and reactive oxygen species (ROS) levels in PC cells using specific dyes. Cell viability was determined using the WST-1 assay. RESULTS: Conditioned media (CM) from gemcitabine-treated PC cells (Gem-CM) provided significant chemoprotection to subsequent gemcitabine toxicity and most of the chemoresistance conferred by Gem-CM resulted from its EVs fraction. Sub-fractionation grouped EVs into distinct subtypes based on size distribution and marker profiles, and exosome (Gem-Exo) was the only sub-fraction that imparted chemoresistance. Gene expression analyses demonstrated upregulation of SOD2 and CAT (ROS-detoxifying genes), and downregulation of DCK (gemcitabine-metabolising gene) in Gem-Exo-treated cells. SOD/CAT upregulation resulted, at least in part, from exosome-mediated transfer of their transcripts and they suppressed basal and gemcitabine-induced ROS production, and partly promoted chemoresistance. DCK downregulation occurred through exosome-delivered miR-155 and either the functional suppression of miR-155 or restoration of DCK led to marked abrogation of Gem-Exo-mediated chemoresistance. CONCLUSIONS: Together, these findings establish a novel role of exosomes in mediating the acquired chemoresistance of PC.
format Online
Article
Text
id pubmed-5344296
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53442962018-02-28 Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK Patel, Girijesh Kumar Khan, Mohammad Aslam Bhardwaj, Arun Srivastava, Sanjeev K Zubair, Haseeb Patton, Mary C Singh, Seema Khushman, Moh'd Singh, Ajay P Br J Cancer Translational Therapeutics BACKGROUND: Chemoresistance is a significant clinical problem in pancreatic cancer (PC) and underlying molecular mechanisms still remain to be completely understood. Here we report a novel exosome-mediated mechanism of drug-induced acquired chemoresistance in PC cells. METHODS: Differential ultracentrifugation was performed to isolate extracellular vesicles (EVs) based on their size from vehicle- or gemcitabine-treated PC cells. Extracellular vesicles size and subtypes were determined by dynamic light scattering and marker profiling, respectively. Gene expression was examined by qRT-PCR and/or immunoblot analyses, and direct targeting of DCK by miR-155 was confirmed by dual-luciferase 3′-UTR reporter assay. Flow cytometry was performed to examine the apoptosis indices and reactive oxygen species (ROS) levels in PC cells using specific dyes. Cell viability was determined using the WST-1 assay. RESULTS: Conditioned media (CM) from gemcitabine-treated PC cells (Gem-CM) provided significant chemoprotection to subsequent gemcitabine toxicity and most of the chemoresistance conferred by Gem-CM resulted from its EVs fraction. Sub-fractionation grouped EVs into distinct subtypes based on size distribution and marker profiles, and exosome (Gem-Exo) was the only sub-fraction that imparted chemoresistance. Gene expression analyses demonstrated upregulation of SOD2 and CAT (ROS-detoxifying genes), and downregulation of DCK (gemcitabine-metabolising gene) in Gem-Exo-treated cells. SOD/CAT upregulation resulted, at least in part, from exosome-mediated transfer of their transcripts and they suppressed basal and gemcitabine-induced ROS production, and partly promoted chemoresistance. DCK downregulation occurred through exosome-delivered miR-155 and either the functional suppression of miR-155 or restoration of DCK led to marked abrogation of Gem-Exo-mediated chemoresistance. CONCLUSIONS: Together, these findings establish a novel role of exosomes in mediating the acquired chemoresistance of PC. Nature Publishing Group 2017-02-28 2017-02-02 /pmc/articles/PMC5344296/ /pubmed/28152544 http://dx.doi.org/10.1038/bjc.2017.18 Text en Copyright © 2017 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Translational Therapeutics
Patel, Girijesh Kumar
Khan, Mohammad Aslam
Bhardwaj, Arun
Srivastava, Sanjeev K
Zubair, Haseeb
Patton, Mary C
Singh, Seema
Khushman, Moh'd
Singh, Ajay P
Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
title Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
title_full Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
title_fullStr Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
title_full_unstemmed Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
title_short Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
title_sort exosomes confer chemoresistance to pancreatic cancer cells by promoting ros detoxification and mir-155-mediated suppression of key gemcitabine-metabolising enzyme, dck
topic Translational Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344296/
https://www.ncbi.nlm.nih.gov/pubmed/28152544
http://dx.doi.org/10.1038/bjc.2017.18
work_keys_str_mv AT patelgirijeshkumar exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck
AT khanmohammadaslam exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck
AT bhardwajarun exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck
AT srivastavasanjeevk exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck
AT zubairhaseeb exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck
AT pattonmaryc exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck
AT singhseema exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck
AT khushmanmohd exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck
AT singhajayp exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck